Priceline franchise satisfaction
February 18, 2013
PRICELINE Pharmacy franchisees
are more satisfied with their lot
than the majority of other franchise
owners across Australia.
The result is part of Priceline
Pharmacy’s annual Franchise
Partner Satisfaction Survey which
found that the company’s franchise
partner satisfaction is significantly
higher than the franchise sector
average.
In addition, when franchisees
were asked what they see as being
the biggest improvement over the
past 12 months, the top theme to
emerge was Priceline Pharmacy's
increased focus on health, including
dispensary.
“We are very pleased to see the
strong levels of satisfaction
evidenced in this year's survey,”
said Stephen Roche, API managing
director and CEO.
“It is a useful benchmark for us
and allows us to get a better
understanding of what we are
doing well, and also what we could
be doing better.
“We're focused on becoming the
best franchise partner in Australia,
and take the view that we are
partners to our franchisees in
ensuring the success and
profitability of their businesses.
“We've put a lot of effort into
ensuring our systems, processes
and the way we market the
Priceline Pharmacy brand help
deliver that, and it's pleasing to see
that franchisees recognise this,” he
added.
Meanwhile, franchisees also
identified market competitive script
pricing as one of the most effective,
and placed it within the top 10
services overall, along with internal
communications.
A number of marketing services
were also featured in the top 10,
including Priceline Pharmacy's
fortnightly catalogues, marketing
materials, and national brand
sponsorships, whilst marketing
materials and data associated with
Priceline's Sister Club also rated
strongly with franchisees.
Despite this, franchisees also
indicated that they want to see
more market competitiveness and
innovation, whilst when asked what
their message was to Priceline
Pharmacy leadership, a large
portion stated that they wanted to
ensure leadership are competitive,
innovative and are market leaders.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Feb 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Feb 13
